Swapnil Gupta

The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial

Douglas L. Boggs, Toral Surti, Aarti Gupta et al. · Psychopharmacology · 2018 · 236 citations

Medicine, Pharmacology, Psychiatry +11

Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial

Deepak Cyril D’Souza, Jose Cortes-Briones, Gina Creatura et al. · The Lancet Psychiatry · 2018 · 192 citations

Medicine, Pharmacology, Pharmacotherapy +15

The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder

Chadi G. Abdallah, Andrea Parolin Jackowski, Ramiro Salas et al. · Neuropsychopharmacology · 2017 · 125 citations

Medicine, Neuroscience, Psychiatry +16

Evidence for the role of lipid peroxides on glycation of hemoglobin and plasma proteins in non-diabetic asthma patients

V Sathiyapriya, Zachariah Bobby, S. Vinod Kumar et al. · Clinica Chimica Acta · 2005 · 32 citations

Life Sciences, Biochemistry, Internal Medicine +16

Deprescribing antipsychotics: a guide for clinicians

Swapnil Gupta, John D. Cahill, Rebecca Miller · BJPsych Advances · 2018 · 30 citations

Pharmacy, Pharmacotherapy, Psychiatry +16